TXMD (TherapeuticsMD) Quality Rank


TXMD TherapeuticsMD Inc TXMD
55 GF Score
Price $1.98
GF Value $2.05
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is TherapeuticsMD Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

TherapeuticsMD Quality Rank Related Terms

TXMD
55GF Score
TherapeuticsMD Inc TXMD
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TherapeuticsMD (TXMD) Overvalued in 2026?

Based on GuruFocus' analysis, TherapeuticsMD stock appears to be undervalued. The current stock price of $1.98 is trading 3.4% below its estimated GF Value™ of $2.05. GuruFocus considers TherapeuticsMD to be Fairly Valued.

Key valuation signals for TXMD:

  • Quality Rank:
  • GF Value™: $2.05 vs. price of $1.98 (3.4% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the TXMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TherapeuticsMD Business Description

Other Exchanges 29TA:Germany
Address 951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
55GF Score

Get the complete analysis for TXMD

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.98
Price
$2.05
GF Value